{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:46:21Z","timestamp":1787024781096,"version":"build-2736575974"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,8,15]]},"DOI":"10.2169\/internalmedicine.2859-23","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T17:11:37Z","timestamp":1702228297000},"page":"2321-2324","source":"Crossref","is-referenced-by-count":4,"title":["Heparin-induced Thrombocytopenia with Anaphylactoid Reaction during Hemodialysis"],"prefix":"10.2169","volume":"63","author":[{"given":"Yoichi","family":"Murakami","sequence":"first","affiliation":[{"name":"Department of Nephrology, Seirei Mikatahara General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuya","family":"Tomoda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Seirei Mikatahara General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzu","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Seirei Mikatahara General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Seirei Mikatahara General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soken","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Seirei Mikatahara General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Seirei Mikatahara General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Seirei Mikatahara General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68: 95-96, 1992.","DOI":"10.1055\/s-0038-1656329"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yamamoto S, Koide M, Matsuo M, et al. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 28: 82-85, 1996.","DOI":"10.1016\/S0272-6386(96)90134-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 120: 4160-4167, 2012.","DOI":"10.1182\/blood-2012-07-443051"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Warkentin TE. 4Ts scoring with hemofiltration or hemodialysis clotting. J Clin Monit Comput 29: 7-9, 2015.","DOI":"10.1007\/s10877-014-9594-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maeda T, Nakagawa K, Murata K, et al. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry. Thromb Haemost 117: 127-138, 2017.","DOI":"10.1160\/TH16-06-0482"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hartman V, Malbrain M, Daelemans R, Meersman P, Zach\u00e9e P. Pseudo-pulmonary embolism as a sign of acute heparin-induced thrombocytopenia in hemodialysis patients: safety of resuming heparin after disappearance of HIT antibodies. Nephron Clin Pract 104: c143-c148, 2006.","DOI":"10.1159\/000094959"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest 141: e495S-e530S, 2012. Erratum in: Chest. 148: 1529, 2015.","DOI":"10.1378\/chest.11-2303"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Greinacher A. Clinical Practice. heparin-induced thrombocytopenia. N Engl J Med 373: 252-261, 2015.","DOI":"10.1056\/NEJMcp1411910"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Matsuo T, Wanaka K, Miyasita K, Prechel M, Walenga JM. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4\/heparin complexes in hemodialysis patients. Thromb Res 129: 474-478, 2012.","DOI":"10.1016\/j.thromres.2011.10.012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Padmanabhan A, Jones CG, Bougie DW, et al. Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. Blood 125: 155-161, 2015.","DOI":"10.1182\/blood-2014-06-580894"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Linkins LA, Warkentin TE. Heparin-induced thrombocytopenia: real-world issues. Semin Thromb Hemost 37: 653-663, 2011.","DOI":"10.1055\/s-0031-1291375"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Birschmann I, Gummert J, Schirmer U, Knabbe C, Sachs UJ, Koster A. Non-transient "self-sustaining" heparin-induced thrombocytopenia: 4-year persistence of a platelet-activating PF4\/heparin-antibody status without heparin exposure. Platelets 25: 634-635, 2014.","DOI":"10.3109\/09537104.2013.849803"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Warkentin TE, Sheppard JA, Chu FV, Kapoor A, Crowther MA, Gangji A. Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities. Blood 125: 195-198, 2015.","DOI":"10.1182\/blood-2014-07-590844"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tejedor Alonso MA, L\u00f3pez Revuelta K, Garc\u00eda Bueno MJ, et al. Thrombocytopenia and anaphylaxis secondary to heparin in a hemodialysis patient. Clin Nephrol 63: 236-240, 2005.","DOI":"10.5414\/CNP63236"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2859-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T23:28:48Z","timestamp":1723850928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2859-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":14,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2859-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"2859-23"}}